27 Pharma Startups in Switzerland to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Novel antiobiotic researcher to fight antimicrobial resistance. |
$13M · Series C | AMR Action Fund, GSK | 1 to 10 | Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@bioversys.com | |
Gene therapy research to tackle genetic diseases. |
$59M · Series A | Gimv | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@anjarium.com | |
Glycanengineering platform. |
$49M · Series A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@glycoera.com | |
Clinical-stage central nervous system (CNS) technology. |
$110M · Series B | Sofinnova Partners, Forbion Capital Partners, BioMedPartners | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@noemapharma.com | |
Platform for observing live cells in 3D without damaging them. |
$20M | Swisscom Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence | B2B, SaaS | Lausanne, Switzerland | •••••••••••@nanolive.ch | |
Developer of oral therapeutics to treat complex autoimmune diseases. |
$3M · Seed | Forty51 Ventures | 1 to 10 | Health Tech, Pharma | Basel, Switzerland | •••••••••••@mystheratx.com | ||
Biotechnology platform developing therapies by investing in people and ideas. |
$25M · Series A | 1 to 10 | Health Tech, Fintech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@rejuveron.com | ||
Platform offering tools to enhance the development of personalized and precision medicine. |
$20M | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Zürich, Switzerland | •••••••••••@bcplatforms.com | ||
Immunotherapy platform for cancer. |
$330k · Pre Seed | Lightspeed Venture Partners, Gimv, BioMedPartners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Zürich, Switzerland | •••••••••••@immunostherapeutics.com | |
Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist. |
$80M · Series C | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Zug, Switzerland | •••••••••••@pharvaris.com | ||
Platform that identifies the ideal treatment for each cancer patient’s disease. |
$7M | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma | Zürich, Switzerland | •••••••••••@navignostics.com | |||
Clinical-stage biopharmaceutical company developing drugs for rare diseases. |
$16M · Series A | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Geneva, Switzerland | •••••••••••@chordtherapeutics.com | ||
Treatments that improve the lives of cancer patients with innovative approaches. |
$26M · Series C | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Basel, Switzerland | •••••••••••@t3pharma.com | ||
Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders. |
$50M · Series A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Basel, Switzerland | •••••••••••@cimeio.com | ||
We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech | B2B | Lausanne, Switzerland | •••••••••••@flowbone.com | |
Platform focusing on the discovery and development of next-generation RNA-based drugs. |
$6M · Seed | 1 to 10 | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@versameb.com | ||
Biotechnology company developing treatments to enhance immune system responses. |
$154k · Pre Seed | Venture Kick | Health Tech, Biotech, Pharma | B2B | Basel, Switzerland | •••••••••••@nextimmune.com | ||
Self-testing kit provider for quick, at-home medical results. |
$1M · Seed | Next Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B, B2C | Lausanne, Switzerland | •••••••••••@testmatehealth.com | |
Bloom Biorenewables is making biomass a true alternative to petroleum. |
$3M | 1 to 10 | Climate Tech & Green Tech, Biotech, Pharma, Energy & Nuclear, Manufacturing | B2B | Fribourg, Switzerland | •••••••••••@bloombiorenewables.com | ||
Software platform that accelerates innovation in the pharmaceutical industry. |
N/A | BACKED VC, Speedinvest, BoxGroup | 11 to 50 | Health Tech, Fintech, Crypto & web3, Biotech, Deep Tech, Pharma | B2B, Marketplace | Schaffhausen, Switzerland | •••••••••••@molecule.to | |
Pharmaceutical manufacturing services for producing medications and therapies. |
$807k · Seed | 1 to 10 | Health Tech, Biotech, Pharma, Fitness, Manufacturing, Service Industry | B2B | Saint Gallen, Switzerland | •••••••••••@galventa.com | ||
Learning platform for the pharma industry. |
N/A | 11 to 50 | Edtech, Pharma | B2B, SaaS | Geneva, Switzerland | •••••••••••@actando.com | ||
Clinical stage R&D company developing therapies to control and modulate pathogenic gene expression. |
N/A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Basel, Switzerland | •••••••••••@cellestia.com | ||
Developer of oral therapeutics to treat complex autoimmune diseases. |
N/A | 1 to 10 | Health Tech, Pharma | Basel, Switzerland | •••••••••••@ | |||
Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations. |
$3M · Pre Seed | Kickfund, Venture Kick, JFG Life Sciences Foundation | 1 to 10 | Biotech, Pharma | B2C | Basel, Switzerland | •••••••••••@nxitherapeutics.com | |
Tumor immunotherapy drug developer. |
$7M · Seed | Fuho Capital, XtalPi, Tiantu Capital | 1 to 10 | Biotech, Pharma | B2C | Lausanne, Switzerland | •••••••••••@lemanbio.com | |
Anti-cancer drug evaluator. |
$167k · Pre Seed | Venture Kick | 1 to 10 | Biotech, Pharma | B2B, SaaS | Lausanne, Switzerland | •••••••••••@calicobiosystems.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.